| Dr Sangmesh Jabshetty, MD | |
|
4800 Alberta Ave, El Paso, TX 79905-2709 | |
| (847) 899-1586 | |
| Not Available |
| Full Name | Dr Sangmesh Jabshetty |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 19 Years |
| Location | 4800 Alberta Ave, El Paso, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801181037 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | P3008 (Texas) | Secondary |
| 207R00000X | Internal Medicine | P3008 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Copley Memorial Hospital | Aurora, IL | Hospital |
| Presence Mercy Medical Center | Aurora, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vna Health Care | 6901879311 | 16 |
News Archive
Celera Corporation and Abbott today announced that they have signed an exclusive distribution agreement to market Celera's CE-marked KIF6 diagnostic test for use on Abbott's CE-marked m2000™ instrument system. The KIF6 genotyping assay detects a genetic marker that may be used in conjunction with clinical evaluation and patient assessment for the identification of individuals at risk for coronary heart disease (CHD), and in patients for whom statin treatment is being considered.
Currently, large doses of chemotherapy are required when treating certain forms of cancer, resulting in toxic side effects. The chemicals enter the body and work to destroy or shrink the tumor, but also harm vital organs and drastically affect bodily functions. Now, scientists at the University of Missouri have proven that a new form of prostate cancer treatment that uses radioactive gold nanoparticles, and was developed at MU, is safe to use in dogs.
Face masks worn by patients infected with tuberculosis (TB) may be able to significantly cut transmission rates to non-infected patients, according to a new study by researchers from the U.S. and South Africa. The study was conducted in a specialized airborne infections research facility in South Africa, which was designed to allow study of methods to control the spread of TB.
The Royal Women's Hospital in Melbourne has mounted an investigation into the accidental termination of a healthy 32-week-old fetus.
Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, will be issuing and completing a forward stock split of 5-1 in the form of a stock dividend on its common shares.
› Verified 4 days ago
| Entity Name | Vna Health Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508826983 PECOS PAC ID: 6901879311 Enrollment ID: O20041004000258 |
News Archive
Celera Corporation and Abbott today announced that they have signed an exclusive distribution agreement to market Celera's CE-marked KIF6 diagnostic test for use on Abbott's CE-marked m2000™ instrument system. The KIF6 genotyping assay detects a genetic marker that may be used in conjunction with clinical evaluation and patient assessment for the identification of individuals at risk for coronary heart disease (CHD), and in patients for whom statin treatment is being considered.
Currently, large doses of chemotherapy are required when treating certain forms of cancer, resulting in toxic side effects. The chemicals enter the body and work to destroy or shrink the tumor, but also harm vital organs and drastically affect bodily functions. Now, scientists at the University of Missouri have proven that a new form of prostate cancer treatment that uses radioactive gold nanoparticles, and was developed at MU, is safe to use in dogs.
Face masks worn by patients infected with tuberculosis (TB) may be able to significantly cut transmission rates to non-infected patients, according to a new study by researchers from the U.S. and South Africa. The study was conducted in a specialized airborne infections research facility in South Africa, which was designed to allow study of methods to control the spread of TB.
The Royal Women's Hospital in Melbourne has mounted an investigation into the accidental termination of a healthy 32-week-old fetus.
Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, will be issuing and completing a forward stock split of 5-1 in the form of a stock dividend on its common shares.
› Verified 4 days ago
| Entity Name | 24 On Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346480431 PECOS PAC ID: 5698688141 Enrollment ID: O20090609000389 |
News Archive
Celera Corporation and Abbott today announced that they have signed an exclusive distribution agreement to market Celera's CE-marked KIF6 diagnostic test for use on Abbott's CE-marked m2000™ instrument system. The KIF6 genotyping assay detects a genetic marker that may be used in conjunction with clinical evaluation and patient assessment for the identification of individuals at risk for coronary heart disease (CHD), and in patients for whom statin treatment is being considered.
Currently, large doses of chemotherapy are required when treating certain forms of cancer, resulting in toxic side effects. The chemicals enter the body and work to destroy or shrink the tumor, but also harm vital organs and drastically affect bodily functions. Now, scientists at the University of Missouri have proven that a new form of prostate cancer treatment that uses radioactive gold nanoparticles, and was developed at MU, is safe to use in dogs.
Face masks worn by patients infected with tuberculosis (TB) may be able to significantly cut transmission rates to non-infected patients, according to a new study by researchers from the U.S. and South Africa. The study was conducted in a specialized airborne infections research facility in South Africa, which was designed to allow study of methods to control the spread of TB.
The Royal Women's Hospital in Melbourne has mounted an investigation into the accidental termination of a healthy 32-week-old fetus.
Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, will be issuing and completing a forward stock split of 5-1 in the form of a stock dividend on its common shares.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sangmesh Jabshetty, MD Po Box 9520, El Paso, TX 79995-9520 Ph: (847) 899-1586 | Dr Sangmesh Jabshetty, MD 4800 Alberta Ave, El Paso, TX 79905-2709 Ph: (847) 899-1586 |
News Archive
Celera Corporation and Abbott today announced that they have signed an exclusive distribution agreement to market Celera's CE-marked KIF6 diagnostic test for use on Abbott's CE-marked m2000™ instrument system. The KIF6 genotyping assay detects a genetic marker that may be used in conjunction with clinical evaluation and patient assessment for the identification of individuals at risk for coronary heart disease (CHD), and in patients for whom statin treatment is being considered.
Currently, large doses of chemotherapy are required when treating certain forms of cancer, resulting in toxic side effects. The chemicals enter the body and work to destroy or shrink the tumor, but also harm vital organs and drastically affect bodily functions. Now, scientists at the University of Missouri have proven that a new form of prostate cancer treatment that uses radioactive gold nanoparticles, and was developed at MU, is safe to use in dogs.
Face masks worn by patients infected with tuberculosis (TB) may be able to significantly cut transmission rates to non-infected patients, according to a new study by researchers from the U.S. and South Africa. The study was conducted in a specialized airborne infections research facility in South Africa, which was designed to allow study of methods to control the spread of TB.
The Royal Women's Hospital in Melbourne has mounted an investigation into the accidental termination of a healthy 32-week-old fetus.
Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, will be issuing and completing a forward stock split of 5-1 in the form of a stock dividend on its common shares.
› Verified 4 days ago
Sara Alhariri, Internal Medicine Medicare: Medicare Enrolled Practice Location: 4801 Alberta Ave, El Paso, TX 79905 Phone: 912-215-8000 | |
Dr. Ney Mckinley Gore Iii, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 5005 N Piedras St, William Beaumont Army Medical Center, El Paso, TX 79920 Phone: 915-569-1382 Fax: 915-569-1233 | |
Armando D. Meza, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4801 Alberta Ave., 4801 Alberta Ave, El Paso, TX 79905 Phone: 915-545-6647 Fax: 915-545-9799 | |
Carlos E. Rodriguez Castro, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4800 Alberta Ave, El Paso, TX 79905 Phone: 915-545-6626 | |
Dr. Pratik Naik, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5005 N Piedras St, El Paso, TX 79920 Phone: 915-742-2180 Fax: 915-742-1919 | |
Alejandro Robles, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 4801 Alberta Ave, El Paso, TX 79905 Phone: 915-215-5200 Fax: 915-215-8640 | |
Dr. Rey Francisco Rosario, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1250 E Cliff Dr, Suite 3e, El Paso, TX 79902 Phone: 915-626-5548 Fax: 915-626-5411 |